Literature DB >> 7985719

Distinguishing between the catalytic potential and apparent expression of tyrosinase activities.

H Zhao1, R E Boissy.   

Abstract

Assays were developed to investigate the catalytic potential and apparent expression of tyrosinase activities. Tyrosine hydroxylase activity determined with cell lysates (in vitro), entire fixed cells (postfixation), or intact living cells (in situ), and 3,4-dihydroxyphenylalanine oxidase assayed spectrophotometrically or by 3,4-dihydroxyphenylalanine staining on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, demonstrated the following results: 1) The in situ assay displayed reduced tyrosine hydroxylase activity in all three tyrosinase-positive oculocutaneous albino (OCA) lines except for Chediak-Higashi Syndrome melanocytes, which displayed normal activity; 2) The in vitro assay had comparable activity of tyrosinase-positive OCA melanocytes as controls, except for one tyrosinase-positive OCA cell line, which demonstrated increased activity; 3) The postfixation assay, compared with the in situ assay, had elevated activity (ie. normalization) of tyrosinase in OCA cells but reduced activity in controls; 4) The spectrophotometric assay for 3,4-dihydroxyphenylalanine oxidase activity correlated very well with the tyrosine hydroxylase activity determined by the in vitro assay; 5) sodium dodecyl sulfate-polyacrylamide gel electrophoresis of melanocyte lysates either stained with 3,4-dihydroxyphenylalanine or immunoblotted with anti-tyrosinase detected abnormal tyrosinase bands in the Chediak-Higashi Syndrome and one line of tyrosinase positive OCA melanocytes, and both lines had release of tyrosinase into the growth media. In conclusion, the selection and combination of these tyrosinase assays would be informative for differentiation and characterization of human albinism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985719     DOI: 10.1097/00000441-199412000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

Authors:  R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 2.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

3.  Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes.

Authors:  F Yang; Z Abdel-Malek; R E Boissy
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

4.  Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

Authors:  Mary S Matsui; Michael J Petris; Yoko Niki; Nevena Karaman-Jurukovska; Neelam Muizzuddin; Masamitsu Ichihashi; Daniel B Yarosh
Journal:  J Invest Dermatol       Date:  2014-10-22       Impact factor: 8.551

5.  AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes.

Authors:  M Huizing; R Sarangarajan; E Strovel; Y Zhao; W A Gahl; R E Boissy
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

6.  Melanocyte-specific proteins are aberrantly trafficked in melanocytes of Hermansky-Pudlak syndrome-type 3.

Authors:  Raymond E Boissy; Bonnie Richmond; Marjan Huizing; Amanda Helip-Wooley; Yang Zhao; Amy Koshoffer; William A Gahl
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.